Diflunisal Tablet
Product Images NDC 70771-1083

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diflunisal (NDC 70771-1083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rx Only (Aa36dffd E56d 43a9 Ab2e C2a6005c8b2b 01)

The image shows a medication packaging label with the text 'Rx only' indicating that the product is available by prescription only. No additional product information or branding is visible in the image.*

FDA Label Image

Structure (Aa36dffd E56d 43a9 Ab2e C2a6005c8b2b 02)

Chemical structure of the active ingredient Diflunisal, showing its molecular arrangement including two fluorine atoms, a carboxyl group, and a hydroxyl group on a biphenyl backbone.*

FDA Label Image

Label (Aa36dffd E56d 43a9 Ab2e C2a6005c8b2b 03)

Diflunisal Tablets USP 500 mg oral tablets label from ZYGenerics, manufactured by Cadila Healthcare Ltd. The label shows NDC 70771-1083-1, quantity of 100 tablets, and storage instructions. It includes a pharmacist note to dispense the medication guide to patients and emphasizes the prescription-only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.